Idexx Laboratories IDXX FX & Other Adjustments

FX & Other Adjustments at other companies

Bio-Rad LaboratoriesBIO

——

RevvityRVTY

——

CAG$7.47M+249%

LPD$1.63M+209%

Water segment revenue$298K+373%

Revenue$1.1B+14.3%

Gross profit$722.7M+15.9%

Operating income$362.6M+14.5%

Net income$278.4M+14.7%

EPS (diluted)$3.47+17.2%

Cash & equivalents$200.5M+22.3%

Total debt$575.5M-22.2%

Total equity$1.6B+7.5%

Total assets$3.4B+5.3%

Operating cash flow$266.2M+11.9%

CapEx$32.0M+6.5%

Free cash flow$234.3M+12.7%

Market cap$43.5B+2.0%

Enterprise value$43.88B+1.7%

P/E39.7×-3.6×

P/S9.8×-0.8×

Gross margin62.1%+0.8pp

Operating margin31.6%+2.5pp

Net margin24.6%+1.9pp

FCF margin24.4%+2.8pp

Return on equity72.9%+13.6pp

Debt / equity0.4×-0.1×

Current ratio1.1×0.0×